Technologies to develop and scale your therapy


The field of cell and gene therapy is transforming the way patients diagnosed with cancers or genetic diseases can be treated. These novel drug candidates provide drastically improved patient outcomes and, in some cases, can be curative. However, manufacturing of such medicines pose complex new challenges. Today, the cost of production still represents a major hurdle for clinical translation and commercialization of these potentially groundbreaking therapies. New technologies are needed to enable robust and cost-efficient manufacturing of high-quality medicines. While the therapeutic opportunities for patients are exciting, the stakes for patients and drug developers are high.

We want to be your partner in this process and drive pioneering therapies to the market. We invest heavily in enabling technologies and building expertise to support development and commercialization of your innovative therapies. Our scientists and engineers have decades of development experience across a broad spectrum of cell types and technologies. This forms the backbone of an extensive service offering, providing you with tailored process and analytical development, GMP manufacturing and regulatory services.

Which area of cell and gene therapy manufacturing are you interested in?


Phase-appropriate services


We provide a wide of range of services to suit your development, clinical and commercial manufacturing milestones. Whether you would like to work together on commercial manufacturing or on bringing your therapy from concept to patients, we can help you achieve your goals.

iPSC manufacturing expertise

the next wave in cell therapy

We can help you overcome scalability challenges by offering expansion from 2D platforms to closed systems with our proprietary L7 GMP platform services. We have developed manufacturing processes to help you achieve scalable production in a GMP setting.

Learn more

Regulatory support dedicated to cell & gene therapy

Rely on a dedicated regulatory partner for the expertise and experience you need to de-risk your therapy's pathway.

Find out more

Tissue sourcing & acquisition

Our in-house Bone Marrow Donor Program’s dedicated full-time staff can help you to navigate through the complexities of tissue sourcing to obtain the clinical and commercial starting material you need.

Find out more

Exosomes development and manufacturing

Leverage our knowledge in 2D/3D cell culture and viral manufacturing expertise, alongside the latest exosome characterization technologies to define your complete path for exosome manufacturing.

Find out more

cell and gene therapies


our global network

Our global network of four centers of excellence spans across three continents: Our sites in Portsmouth, NH (USA) and Singapore (SG) provide clinical and commercial manufacturing, while Pearland, TX (USA) and Geleen/Maastricht (NL) offer integrated cell and gene therapy services that include process/analytical development, as well as clinical and commercial manufacturing.

Portsmouth, NH, USA

Clinical Manufacturing, Commercial Manufacturing, Cell and Gene Manufacturing

101 International Drive
Portsmouth, NH 03801
United States of America

Tuas, Singapore

Production, Sales & Support

35 Tuas South Ave 6
Tuas 637377
Singapore

Houston, TX, USA

Clinical Manufacturing, Commercial Manufacturing, Cell and Gene Manufacturing, Viral Vector Manufacturing

14905 Kirby Dr
Houston, TX 77047
United States of America

Geleen, The Netherlands

Clinical Manufacturing, Commercial Manufacturing, Cell and Gene Manufacturing, Process Development, Analytical Development

Urmonderbaan 20B
Geleen
Netherlands